Medical Properties Trust (MPT)
Market Price (9/1/2026): $4.04 | Market Cap: $2.4 BilSector: Real Estate | Industry: Health Care REITs
Medical Properties Trust (MPT)
Market Price (9/1/2026): $4.04Market Cap: $2.4 BilSector: Real EstateIndustry: Health Care REITs
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, Dividend Yield is 8.7%, FCF Yield is 9.6% Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 57% Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 22%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 396% Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.6% Significant short interestShort Interest Days-to-CoverDTC = (Short Interest Share Quantity) / (Average Daily Trading Volume). Reflects how many days it would take to cover (close out) the short interest based on average volumes. High DTC can signify an increased risk of a short squeeze. is 15.55, Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 24% Key risksMPT key risks include [1] potential nonpayment from its holdings of lower-rated "Baa" or "BBB" municipal securities. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, Dividend Yield is 8.7%, FCF Yield is 9.6% |
| Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 57% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 22%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 396% |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -3.6% |
| Significant short interestShort Interest Days-to-CoverDTC = (Short Interest Share Quantity) / (Average Daily Trading Volume). Reflects how many days it would take to cover (close out) the short interest based on average volumes. High DTC can signify an increased risk of a short squeeze. is 15.55, Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 24% |
| Key risksMPT key risks include [1] potential nonpayment from its holdings of lower-rated "Baa" or "BBB" municipal securities. |
Qualitative Assessment
AI Analysis | Feedback
Medical Properties Trust (MPT) stock has lost about 20% since 5/31/2026 because of the following key factors:
1. Elevated Interest Expense from Debt Refinancing Weighs on Future Earnings. Medical Properties Trust completed a significant private offering of approximately $2.4 billion in 9.25% senior secured notes due 2032 on August 10, 2026, to refinance maturing debt, including all 2026 notes and a portion of 2027 notes. While this transaction extended maturities and reduced total principal debt by approximately $123 million, the high 9.25% interest rate is expected to increase funding costs and result in a $0.057 per share quarterly headwind to normalized funds from operations (NFFO). This higher cost of capital creates a drag on future profitability, despite Q2 2026 NFFO of $0.15 per share meeting analyst consensus estimates.
2. Persistent Tenant Financial Difficulties and Rent Collection Challenges. Ongoing tenant strains continue to impact MPT's performance. For instance, Healthcare Systems of America (HSA) is reportedly "paying reduced rent and dealing with billing and collection issues," contributing to concerns about "uneven cash rent". During fiscal Q2 2026 (ended June 30, 2026), MPT advanced an additional $50 million in working capital to HSA, with only $20 million repaid and another $20 million expected later in Q3 2026, highlighting the need for ongoing financial support for certain operators. These issues underscore an underlying risk to consistent cash flow and contribute to investor apprehension regarding the company's "multi-year clean up story".
Show more
Medical Properties Trust (MPT) stock has lost about 20% since 5/31/2026 because of the following key factors:
1. Elevated Interest Expense from Debt Refinancing Weighs on Future Earnings. Medical Properties Trust completed a significant private offering of approximately $2.4 billion in 9.25% senior secured notes due 2032 on August 10, 2026, to refinance maturing debt, including all 2026 notes and a portion of 2027 notes. While this transaction extended maturities and reduced total principal debt by approximately $123 million, the high 9.25% interest rate is expected to increase funding costs and result in a $0.057 per share quarterly headwind to normalized funds from operations (NFFO). This higher cost of capital creates a drag on future profitability, despite Q2 2026 NFFO of $0.15 per share meeting analyst consensus estimates.
2. Persistent Tenant Financial Difficulties and Rent Collection Challenges. Ongoing tenant strains continue to impact MPT's performance. For instance, Healthcare Systems of America (HSA) is reportedly "paying reduced rent and dealing with billing and collection issues," contributing to concerns about "uneven cash rent". During fiscal Q2 2026 (ended June 30, 2026), MPT advanced an additional $50 million in working capital to HSA, with only $20 million repaid and another $20 million expected later in Q3 2026, highlighting the need for ongoing financial support for certain operators. These issues underscore an underlying risk to consistent cash flow and contribute to investor apprehension regarding the company's "multi-year clean up story".
3. Negative Analyst Sentiment and Reduced Price Targets. Analyst ratings and price targets reflected cautious sentiment during the period, contributing to downward pressure on the stock. Royal Bank of Canada lowered its price target for MPT from $5.00 to $4.50 in June 2026. Additionally, Weiss Ratings downgraded the stock from a "sell (d+)" to a "sell (d)" rating in August 2026, while Bank of America Securities also reduced its price target from $5.00 to $4.25. The overall analyst consensus rating for MPT is "Reduce," with an average price target of $4.50. These downgrades and lowered expectations likely amplified selling pressure, as the stock reached a new 52-week low of $3.96 on August 31, 2026.
4. Concerns Regarding Dividend Sustainability Amidst Net Losses. Despite maintaining a regular quarterly dividend of $0.09 per share, most recently paid in July 2026 and declared again on August 13, 2026, for October 2026, the company reported a net loss of ($0.01) per share for fiscal Q2 2026. Although revenue for the quarter increased by 7.9% year-over-year to $259.3 million, the negative net earnings indicate that the dividend payout ratio is "highly unfavorable". This disparity between consistent dividend payments and reported net losses raises questions about the long-term sustainability of the dividend, particularly in light of increased interest expenses from recent debt refinancing, contributing to investor uncertainty.
Show less
Stock Movement Drivers
Fundamental Drivers
The -20.8% change in MPT stock from 5/31/2026 to 8/31/2026 was primarily driven by a -22.2% change in the company's P/S Multiple.| (LTM values as of) | 5312026 | 8312026 | Change |
|---|---|---|---|
| Stock Price ($) | 5.01 | 3.97 | -20.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,000 | 1,019 | 1.9% |
| P/S Multiple | 3.0 | 2.3 | -22.2% |
| Shares Outstanding (Mil) | 598 | 598 | 0.0% |
| Cumulative Contribution | -20.8% |
Market Drivers
5/31/2026 to 8/31/2026| Return | Correlation | |
|---|---|---|
| MPT | -20.8% | |
| Market (SPY) | 1.4% | 16.0% |
| Sector (XLRE) | 0.3% | 49.2% |
Fundamental Drivers
The -28.4% change in MPT stock from 2/28/2026 to 8/31/2026 was primarily driven by a -32.1% change in the company's P/S Multiple.| (LTM values as of) | 2282026 | 8312026 | Change |
|---|---|---|---|
| Stock Price ($) | 5.55 | 3.97 | -28.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 972 | 1,019 | 4.9% |
| P/S Multiple | 3.4 | 2.3 | -32.1% |
| Shares Outstanding (Mil) | 601 | 598 | 0.5% |
| Cumulative Contribution | -28.4% |
Market Drivers
2/28/2026 to 8/31/2026| Return | Correlation | |
|---|---|---|
| MPT | -28.4% | |
| Market (SPY) | 12.1% | 21.1% |
| Sector (XLRE) | 1.3% | 43.4% |
Fundamental Drivers
The -5.2% change in MPT stock from 8/31/2025 to 8/31/2026 was primarily driven by a -14.7% change in the company's P/S Multiple.| (LTM values as of) | 8312025 | 8312026 | Change |
|---|---|---|---|
| Stock Price ($) | 4.19 | 3.97 | -5.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 922 | 1,019 | 10.6% |
| P/S Multiple | 2.7 | 2.3 | -14.7% |
| Shares Outstanding (Mil) | 601 | 598 | 0.5% |
| Cumulative Contribution | -5.2% |
Market Drivers
8/31/2025 to 8/31/2026| Return | Correlation | |
|---|---|---|
| MPT | -5.2% | |
| Market (SPY) | 19.9% | 12.2% |
| Sector (XLRE) | 6.9% | 30.5% |
Fundamental Drivers
The -29.3% change in MPT stock from 8/31/2023 to 8/31/2026 was primarily driven by a -28.2% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 8312023 | 8312026 | Change |
|---|---|---|---|
| Stock Price ($) | 5.62 | 3.97 | -29.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,420 | 1,019 | -28.2% |
| P/S Multiple | 2.4 | 2.3 | -1.6% |
| Shares Outstanding (Mil) | 598 | 598 | 0.1% |
| Cumulative Contribution | -29.3% |
Market Drivers
8/31/2023 to 8/31/2026| Return | Correlation | |
|---|---|---|
| MPT | -29.3% | |
| Market (SPY) | 76.3% | 20.7% |
| Sector (XLRE) | 30.8% | 40.8% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| MPT Return | 14% | -49% | -50% | -12% | 35% | -15% | -71% |
| Peers Return | 17% | -16% | 11% | 23% | 20% | 22% | 96% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 13% | 105% |
Monthly Win Rates [3] | |||||||
| MPT Win Rate | 42% | 33% | 50% | 50% | 58% | 62% | |
| Peers Win Rate | 50% | 38% | 58% | 65% | 58% | 65% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| MPT Max Drawdown | -12% | -56% | -68% | -40% | -35% | -31% | |
| Peers Max Drawdown | -16% | -35% | -25% | -17% | -14% | -12% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: VTR, WELL, DOC, OHI, HR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/31/2026 (YTD)
How Low Can It Go
| Event | MPT | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -11.0% | -18.8% |
| % Gain to Breakeven | 12.3% | 23.1% |
| Time to Breakeven | 91 days | 79 days |
| 2020 COVID-19 Crash | ||
| % Loss | -44.6% | -33.7% |
| % Gain to Breakeven | 80.7% | 50.9% |
| Time to Breakeven | 325 days | 140 days |
| 2016-2017 Trump Reflation Bond Selloff | ||
| % Loss | -22.2% | -3.7% |
| % Gain to Breakeven | 28.6% | 3.9% |
| Time to Breakeven | 377 days | 6 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -17.8% | -12.2% |
| % Gain to Breakeven | 21.7% | 13.9% |
| Time to Breakeven | 20 days | 62 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -22.5% | -6.8% |
| % Gain to Breakeven | 29.0% | 7.3% |
| Time to Breakeven | 35 days | 15 days |
| 2013 Taper Tantrum | ||
| % Loss | -26.2% | -0.2% |
| % Gain to Breakeven | 35.5% | 0.2% |
| Time to Breakeven | 487 days | 1 days |
In The Past
Medical Properties Trust's stock fell -11.0% during the 2025 US Tariff Shock. Such a loss loss requires a 12.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | MPT | S&P 500 |
|---|---|---|
| 2020 COVID-19 Crash | ||
| % Loss | -44.6% | -33.7% |
| % Gain to Breakeven | 80.7% | 50.9% |
| Time to Breakeven | 325 days | 140 days |
| 2016-2017 Trump Reflation Bond Selloff | ||
| % Loss | -22.2% | -3.7% |
| % Gain to Breakeven | 28.6% | 3.9% |
| Time to Breakeven | 377 days | 6 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -22.5% | -6.8% |
| % Gain to Breakeven | 29.0% | 7.3% |
| Time to Breakeven | 35 days | 15 days |
| 2013 Taper Tantrum | ||
| % Loss | -26.2% | -0.2% |
| % Gain to Breakeven | 35.5% | 0.2% |
| Time to Breakeven | 487 days | 1 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -31.4% | -17.9% |
| % Gain to Breakeven | 45.7% | 21.8% |
| Time to Breakeven | 378 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -69.2% | -53.4% |
| % Gain to Breakeven | 224.8% | 114.4% |
| Time to Breakeven | 219 days | 1085 days |
In The Past
Medical Properties Trust's stock fell -11.0% during the 2025 US Tariff Shock. Such a loss loss requires a 12.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Medical Properties Trust (MPT)
Medical Properties Trust (MPT) is a real estate investment trust (REIT) that specializes in owning and developing hospital facilities. Established in 2003, the company has grown to become one of the world's largest owners of hospitals, boasting a portfolio of 431 facilities and roughly 43,000 licensed beds across nine countries and four continents.
MPT's core business involves acquiring hospital real estate and subsequently entering into net-lease agreements with healthcare operators. This financing model serves as its main product, allowing hospital operators to sell their valuable real estate assets to MPT. By doing so, operators can unlock significant capital previously tied up in property ownership. This freed-up capital can then be strategically reinvested into vital areas such as facility improvements, technology upgrades, and other operational enhancements to better serve their patients and communities.
AI Analysis | Feedback
Here are 1-3 brief analogies for Medical Properties Trust (MPT):
- Medical Properties Trust is like an American Tower for hospitals, owning and leasing critical infrastructure for healthcare operators.
- Medical Properties Trust is like a Simon Property Group for hospitals, acting as a specialized landlord for healthcare facilities rather than malls.
AI Analysis | Feedback
- Hospital Real Estate Leasing: MPT leases hospital facilities to healthcare operators under long-term net-lease agreements.
- Hospital Real Estate Financing: MPT provides capital solutions to hospital operators by acquiring their real estate assets and leasing them back (sale-leaseback transactions).
AI Analysis | Feedback
Medical Properties Trust (MPT) sells its services primarily to other companies, specifically hospital operating companies that lease MPT's hospital facilities. MPT's major customers are the tenants that operate the hospitals owned by MPT.
The major customer companies for Medical Properties Trust include:
- Steward Health Care System (Private company)
- Prospect Medical Holdings (Private company)
- Prime Healthcare (Private company)
- CommonSpirit Health (Private, non-profit organization)
- Priory Group (Private company, UK-based operator)
AI Analysis | Feedback
AI Analysis | Feedback
Edward K. Aldag, Jr. Chairman, President & Chief Executive Officer
Edward K. Aldag, Jr. launched Medical Properties Trust, Inc. in 2003 as a real estate investment trust focused exclusively on hospitals. Prior to founding MPT, he served as President and a board member of Guilford Medical Properties, Inc. He was also President of Guilford Capital Corporation from 1998 to 2001 and its Executive Vice President, Chief Operating Officer, and a board member from 1990 to 1998.
R. Steven Hamner Executive Vice President & Chief Financial Officer
R. Steven Hamner is a co-founder of Medical Properties Trust, Inc., established in 2003. He has served as Executive Vice President and Chief Financial Officer since September 2003. Before MPT, from October 2001 to March 2004, he was the Managing Director of Transaction Analysis LLC, a firm offering accounting and consulting services to commercial real estate owners. From June 1998 to September 2001, he was Vice President and Chief Financial Officer of United Investors Realty Trust, a publicly traded REIT. Earlier in his career, he worked for Ernst & Young LLP and its predecessors for ten years as a Certified Public Accountant.
Rosa H. Williams Senior Vice President of Operations
Prior to joining Medical Properties Trust, Rosa H. Williams was the Chief Financial Officer of a Birmingham hospital, which was a joint venture partnership among 52 physicians. She also spent 15 years at Encompass Health (formerly HealthSouth Corp.), holding various operational roles in their ambulatory divisions, including surgery, diagnostic imaging, and physical therapy. Her experience also includes seven years in the finance department at another Birmingham hospital, and she began her career at Arthur Andersen & Co.
J. Kevin Hanna Senior Vice President, Controller & Chief Accounting Officer
Before joining Medical Properties Trust in 2008, J. Kevin Hanna served as Controller for Fruit of the Loom, Inc., a Berkshire Hathaway subsidiary, and Russell Corp., a global consumer products company.
Larry H. Portal Senior Vice President, Senior Advisor to the CEO
Larry H. Portal joined MPT in 2019. Previously, he was a Senior Managing Director at FTI Consulting, where he advised REIT clients on mergers and acquisitions, tax structuring, and IPO advisory. He started his career in tax practice at Ernst & Young and was the head of Tax for Vornado Realty Trust from 1997 to 2002.
AI Analysis | Feedback
The key risks to Medical Properties Trust (MPT) are primarily concentrated around the financial health of its major tenants, its substantial debt burden, and resulting profitability challenges.
-
Tenant Concentration and Financial Health of Key Tenants
Medical Properties Trust has faced significant challenges due to its high exposure to a few major tenants, most notably Steward Health Care and Prospect Medical. Both of these large operators have experienced substantial financial difficulties, including Steward Health Care filing for Chapter 11 bankruptcy in 2024 and Prospect Medical undergoing restructuring and bankruptcy in January 2025. These issues have led to delayed or unpaid rents, asset impairments, and the necessity for MPT to transition properties to new operators, directly impacting its cash flow and overall financial performance. The company has been actively working to reduce its reliance on these tenants and diversify its tenant base.
-
High Leverage, Debt Levels, and Interest Rate Sensitivity
MPT operates with a significant amount of debt, with a debt-to-equity ratio of 2.13 and long-term debt nearing $9.82 billion as of recent reports. The company's financial strength is rated as poor due to this high leverage and a low interest coverage ratio of 1.1, indicating potential solvency risks. Rising interest rates pose a substantial risk by increasing the cost of financing and potentially depressing property valuations. This sensitivity to interest rates makes refinancing existing debt and covering interest payments a critical challenge for MPT.
-
Profitability Challenges and Declining Revenue
Medical Properties Trust has experienced a decline in revenue, with a 3-year revenue growth decline of 14.4%. The company also faces profitability issues, reflected in negative net margins and a reported consolidated net loss. While the gross margin remains robust, MPT has struggled to translate revenue into sustainable profit, particularly due to the operational challenges and financial instability of its key tenants, which directly affect rental income.
AI Analysis | Feedback
The accelerating shift in healthcare delivery towards outpatient procedures, ambulatory care centers, and home-based or virtual care models could fundamentally decrease the long-term demand for traditional inpatient hospital beds and large acute-care facilities. This evolving trend threatens to erode the value of Medical Properties Trust's real estate portfolio and reduce the profitability and solvency of its hospital operator tenants, thereby impacting MPT's rental income and asset valuations.
AI Analysis | Feedback
AI Analysis | Feedback
- Increased Annualized Cash Rent from New and Restructured Lease Agreements: The company anticipates achieving at least $1 billion in annualized cash rent from its current portfolio by the end of 2026. This includes the ramping up of a new lease for six California hospitals, formerly operated by Prospect Medical Holdings, which is projected to generate $45 million in annual rent by December 2026. Additionally, a restructuring transaction with Vibra Healthcare resulted in a new 20-year master lease and an $18 million one-time rent payment.
- Strategic Acquisitions of New Facilities: MPT has recently engaged in selective portfolio acquisitions, including one post-acute facility in the U.S. for approximately $32 million and another in Europe for approximately €23 million. These acquisitions are noted for being historically strong performers with attractive coverage metrics.
- Improved Performance and Recovery of the Existing Diversified Portfolio: The company has observed an accelerated portfolio operating recovery, with general acute care operators reporting significant year-over-year increases in EBITDARM. Post-acute care and behavioral health portfolios have also demonstrated improved EBITDARM coverage. MPT's strong international portfolio, especially in Germany, continues to contribute positively to its performance.
AI Analysis | Feedback
Medical Properties Trust (MPT) Capital Allocation Decisions (2021-2026)
Share Repurchases
- Medical Properties Trust's Board of Directors authorized a new $150 million share repurchase program in October 2025.
- Under this program, approximately 4.5 million shares were repurchased for $23.4 million during the fourth quarter of 2025.
- Previously, in October 2022, the Board authorized the repurchase of up to $500 million of common stock, under which 1.6 million shares were repurchased in 2022 for $17.9 million.
Share Issuance
- In January 2021, Medical Properties Trust completed an underwritten public offering of 36.8 million shares, generating net proceeds of approximately $711 million.
- Throughout 2021, the company also sold 16.3 million shares under its at-the-market equity offering program, resulting in net proceeds of approximately $340 million.
Inbound Investments
- In September 2021, Medical Properties Trust partnered with Macquarie Infrastructure Partners V (MIP V), which acquired a 50% interest in a portfolio of eight Massachusetts hospitals. This transaction generated approximately $1.3 billion in proceeds for MPT, used to repay debt and fund new investments.
- In February 2025, MPT privately placed $2.5 billion of secured notes at a 7.9% interest rate to address debt maturities and bolster liquidity.
Outbound Investments
- Medical Properties Trust acquired one post-acute facility in the U.S. for approximately $32 million in the fourth quarter of 2025 and another post-acute facility in Europe for approximately €23 million in February 2026.
- In 2021, the company announced the planned acquisition of 18 behavioral health hospital facilities (Springstone) for $950 million, expected to close in the second half of that year.
- The company's strategy consistently involves acquiring and developing net-leased hospital facilities globally to support healthcare operators.
Capital Expenditures
- Capital expenditures for Medical Properties Trust in 2025 were approximately $74 million, representing a halving from the previous year.
- The primary focus of MPT's capital expenditure, as part of its business model, is to enable hospital operators to fund facility improvements, technology upgrades, and other investments in operations by unlocking the value of their real estate assets.
Peer Outperformance in Health Care REITs
| Ticker | Name | Rev Growth 3Y Avg | P/E | 1Y | 3Y | 5Y | 5Y Gap |
|---|---|---|---|---|---|---|---|
| MPT | Medical Properties Trust | -3.6% | -78.6x | -5.2% | -30.0% | -71.2% | — |
| HR | Healthcare Realty Trust | -4.9% | -75.0x | 15.2% | 32.6% | 0.9% | +72pp |
| Industry | Names | 1Y med | 3Y med | 5Y med | Top 3 by 5Y |
|---|---|---|---|---|---|
| Health Care REITs ← | 14 | 17.4% | 59.2% | 58.2% | WELL 202% · CTRE 123% · DHC 117% |
| Retail REITs | 22 | 12.9% | 36.4% | 34.6% | IVT 1583% · SKT 175% · SPG 104% |
| Real Estate Development | 6 | 0.4% | 10.4% | 19.6% | JOE 47% · AXR 44% · FOR 35% |
| Other Specialized REITs | 11 | 3.1% | 18.4% | 15.5% | IRM 190% · LAMR 66% · EPR 65% |
| Hotel & Resort REITs | 16 | 33.0% | 31.9% | 8.5% | RHP 77% · HST 70% · DRH 55% |
| Industrial REITs | 11 | 15.9% | 19.6% | 4.7% | EGP 27% · FR 26% · PLD 17% |
| Diversified REITs | 12 | 8.6% | 25.5% | -7.0% | CTO 68% · WPC 21% · EPRT 16% |
| Single-Family Residential REITs | 4 | -2.7% | 3.3% | -17.2% | AMH -10% · ELS -16% · INVH -18% |
| Multi-Family Residential REITs | 13 | -5.5% | 3.7% | -17.5% | AIV 13% · ESS 1% · BRT -5% |
| Real Estate Services | 27 | -14.5% | -12.4% | -26.7% | REAX 873% · MDRR 572% · CHCI 239% |
| Office REITs | 18 | -0.2% | 15.3% | -30.2% | PSTL 59% · CDP 57% · SLG 9% |
| Telecom Tower REITs | 3 | -10.5% | -9.0% | -43.7% | AMT -31% · SBAC -44% · CCI -51% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | - |
| Mkt Cap | 14.0 |
| Rev LTM | 2,116 |
| Op Inc LTM | 617 |
| FCF LTM | 991 |
| FCF 3Y Avg | 819 |
| CFO LTM | 1,061 |
| CFO 3Y Avg | 971 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 12.8% |
| Rev Chg 3Y Avg | 13.2% |
| Rev Chg Q | 13.7% |
| QoQ Delta Rev Chg LTM | 3.2% |
| Op Inc Chg LTM | 15.8% |
| Op Inc Chg 3Y Avg | 23.1% |
| Op Mgn LTM | 15.9% |
| Op Mgn 3Y Avg | 15.4% |
| QoQ Delta Op Mgn LTM | -0.3% |
| CFO/Rev LTM | 33.7% |
| CFO/Rev 3Y Avg | 35.8% |
| FCF/Rev LTM | 23.7% |
| FCF/Rev 3Y Avg | 29.5% |
Price Behavior
| Market Price | $3.97 | |
| Market Cap ($ Bil) | 2.4 | |
| First Trading Date | 02/02/2026 | |
| Distance from 52W High | -31.5% | |
| 50 Days | 200 Days | |
| DMA Price | $4.46 | $4.86 |
| DMA Trend | down | down |
| Distance from DMA | -11.1% | -18.2% |
| 3M | 1YR | |
| Volatility | 35.6% | 37.5% |
| Downside Capture | 155.42 | 39.42 |
| Upside Capture | 46.93 | 24.70 |
| Correlation (SPY) | 14.8% | 12.0% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.55 | 0.92 | 0.41 | 0.51 | 0.37 | 0.76 |
| Up Beta | -0.18 | -0.26 | 0.01 | 0.34 | 0.59 | 0.71 |
| Down Beta | -3.96 | -1.12 | -0.53 | -0.14 | 0.32 | 0.56 |
| Up Capture | 146% | 120% | 33% | 29% | 17% | 43% |
| Bmk +ve Days | 10 | 21 | 32 | 68 | 138 | 427 |
| Stock +ve Days | 8 | 16 | 21 | 50 | 111 | 336 |
| Down Capture | 595% | 269% | 148% | 127% | 48% | 102% |
| Bmk -ve Days | 11 | 21 | 32 | 59 | 113 | 324 |
| Stock -ve Days | 12 | 23 | 39 | 70 | 125 | 383 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MPT | |
|---|---|---|---|---|
| MPT | -3.1% | 37.5% | -0.01 | - |
| Sector ETF (XLRE) | 7.5% | 14.0% | 0.28 | 31.0% |
| Equity (SPY) | 19.3% | 12.8% | 1.11 | 12.1% |
| Gold (GLD) | 29.8% | 29.0% | 0.89 | 6.6% |
| Commodities (DBC) | 41.3% | 20.4% | 1.58 | -18.1% |
| Real Estate (VNQ) | 9.2% | 13.7% | 0.40 | 33.9% |
| Bitcoin (BTCUSD) | -30.9% | 43.7% | -0.72 | 5.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MPT | |
|---|---|---|---|---|
| MPT | -21.3% | 50.0% | -0.30 | - |
| Sector ETF (XLRE) | 2.0% | 19.2% | 0.00 | 45.5% |
| Equity (SPY) | 12.9% | 17.2% | 0.57 | 28.0% |
| Gold (GLD) | 19.4% | 18.7% | 0.84 | 7.1% |
| Commodities (DBC) | 11.0% | 19.5% | 0.44 | 1.6% |
| Real Estate (VNQ) | 1.9% | 18.9% | -0.00 | 47.9% |
| Bitcoin (BTCUSD) | 9.5% | 52.7% | 0.36 | 10.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MPT | |
|---|---|---|---|---|
| MPT | -6.0% | 41.7% | -0.01 | - |
| Sector ETF (XLRE) | 6.4% | 20.4% | 0.26 | 58.0% |
| Equity (SPY) | 15.2% | 17.9% | 0.72 | 41.2% |
| Gold (GLD) | 12.3% | 16.3% | 0.62 | 8.3% |
| Commodities (DBC) | 7.6% | 18.1% | 0.34 | 10.6% |
| Real Estate (VNQ) | 4.9% | 20.7% | 0.20 | 60.7% |
| Bitcoin (BTCUSD) | 63.4% | 66.2% | 1.03 | 10.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Updated 8/19/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 8/10/2026 | -11.7% | -11.1% | |
| 4/30/2026 | -3.7% | 1.9% | -0.4% |
| 2/19/2026 | 12.1% | 7.3% | -10.7% |
| 10/30/2025 | 6.4% | 0.2% | 15.6% |
| 7/31/2025 | -0.2% | 0.7% | 6.5% |
| 5/1/2025 | -6.9% | -8.5% | -17.2% |
| 2/27/2025 | 17.0% | 20.1% | 31.9% |
| 11/7/2024 | -1.1% | -4.1% | -9.8% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 14 | 11 |
| # Negative | 11 | 10 | 12 |
| Median Positive | 6.1% | 4.5% | 13.8% |
| Median Negative | -3.7% | -5.2% | -10.0% |
| Max Positive | 17.0% | 21.5% | 31.9% |
| Max Negative | -14.1% | -22.7% | -38.3% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 8/10/2026 | -11.7% | -11.1% | |
| 4/30/2026 | -3.7% | 1.9% | -0.4% |
| 2/19/2026 | 12.1% | 7.3% | -10.7% |
| 10/30/2025 | 6.4% | 0.2% | 15.6% |
| 7/31/2025 | -0.2% | 0.7% | 6.5% |
| 5/1/2025 | -6.9% | -8.5% | -17.2% |
| 2/27/2025 | 17.0% | 20.1% | 31.9% |
| 11/7/2024 | -1.1% | -4.1% | -9.8% |
| 8/8/2024 | 4.4% | 2.0% | 7.4% |
| 5/9/2024 | 5.2% | 21.5% | 20.4% |
| 2/21/2024 | 5.6% | 15.8% | 18.1% |
| 10/26/2023 | 15.7% | 4.5% | 4.7% |
| 8/8/2023 | -14.1% | -22.7% | -30.6% |
| 4/27/2023 | 7.6% | 4.5% | -3.0% |
| 2/23/2023 | -8.7% | -17.5% | -38.3% |
| 10/27/2022 | 7.7% | 1.5% | 20.6% |
| 8/3/2022 | -4.9% | -4.0% | -13.6% |
| 4/28/2022 | 6.1% | 7.4% | 5.2% |
| 2/3/2022 | -2.8% | -4.1% | -10.2% |
| 10/28/2021 | 2.0% | -0.7% | 1.5% |
| 7/29/2021 | 0.3% | -3.1% | -4.4% |
| 4/29/2021 | -2.2% | -6.3% | -6.4% |
| 2/4/2021 | -0.2% | 2.5% | -2.9% |
| 10/29/2020 | 5.5% | 9.9% | 13.8% |
| SUMMARY STATS | |||
| # Positive | 13 | 14 | 11 |
| # Negative | 11 | 10 | 12 |
| Median Positive | 6.1% | 4.5% | 13.8% |
| Median Negative | -3.7% | -5.2% | -10.0% |
| Max Positive | 17.0% | 21.5% | 31.9% |
| Max Negative | -14.1% | -22.7% | -38.3% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/10/2026 | 10-Q |
| 03/31/2026 | 05/08/2026 | 10-Q |
| 12/31/2025 | 02/26/2026 | 10-K |
| 09/30/2025 | 11/07/2025 | 10-Q |
| 06/30/2025 | 08/08/2025 | 10-Q |
| 03/31/2025 | 05/09/2025 | 10-Q |
| 12/31/2024 | 03/03/2025 | 10-K |
| 09/30/2024 | 11/12/2024 | 10-Q |
| 06/30/2024 | 08/09/2024 | 10-Q |
| 03/31/2024 | 05/29/2024 | 10-Q |
| 12/31/2023 | 02/29/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/09/2023 | 10-Q |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 03/01/2023 | 10-K |
| 09/30/2022 | 11/09/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/10/2026 | 10-Q |
| 03/31/2026 | 05/08/2026 | 10-Q |
| 12/31/2025 | 02/26/2026 | 10-K |
| 09/30/2025 | 11/07/2025 | 10-Q |
| 06/30/2025 | 08/08/2025 | 10-Q |
| 03/31/2025 | 05/09/2025 | 10-Q |
| 12/31/2024 | 03/03/2025 | 10-K |
| 09/30/2024 | 11/12/2024 | 10-Q |
| 06/30/2024 | 08/09/2024 | 10-Q |
| 03/31/2024 | 05/29/2024 | 10-Q |
| 12/31/2023 | 02/29/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/09/2023 | 10-Q |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 03/01/2023 | 10-K |
| 09/30/2022 | 11/09/2022 | 10-Q |
| 06/30/2022 | 08/09/2022 | 10-Q |
| 03/31/2022 | 05/10/2022 | 10-Q |
| 12/31/2021 | 03/01/2022 | 10-K |
| 09/30/2021 | 11/09/2021 | 10-Q |
| 06/30/2021 | 08/09/2021 | 10-Q |
| 03/31/2021 | 05/10/2021 | 10-Q |
| 12/31/2020 | 03/01/2021 | 10-K |
| 09/30/2020 | 11/09/2020 | 10-Q |
| 06/30/2020 | 08/10/2020 | 10-Q |
| 03/31/2020 | 05/11/2020 | 10-Q |
| 12/31/2019 | 02/27/2020 | 10-K |
| 09/30/2019 | 11/12/2019 | 10-Q |
Recent Forward Guidance
Updated 8/11/2026Latest: Q2 2026 Earnings Reported 8/10/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q3 2026 Asset Sale Proceeds | 172.00 Mil | ||||||
| Q3 2026 Infracore Equity Investment Proceeds | 35.00 Mil | ||||||
| Q3 2026 HSA Working Capital Repayment | 20.00 Mil | ||||||
Prior: Q1 2026 Earnings Reported 4/30/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Annualized Cash Rent | 1.00 Bil | 0 | Affirmed | Guidance: 1.00 Bil for 2026 | |||
Q4 2025 Earnings Reported 2/19/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Pro forma annualized cash rent | 1.00 Bil | 0 | Affirmed | Guidance: 1.00 Bil for 2026 | |||
Q3 2025 Earnings Reported 10/30/2025
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q4 2025 Cash Collections | 22.00 Mil | 29.4% | Higher New | Actual: 17.00 Mil for Q3 2025 | |||
| 2026 Stabilized Annual Cash Rent | 45.00 Mil | ||||||
| 2026 Pro Rata Annualized Cash Rent | 1.00 Bil | 0 | Affirmed | Guidance: 1.00 Bil for Q4 2026 | |||
Insider Activity
Updated 8/20/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Hanna, James Kevin | Senior VP, Controller & CAO | Direct | Buy | 8202026 | 4.15 | 2,300 | 9,545 | 2,251,392 | Form |
| 2 | Hooper, Rosa Handley | SVP of Operations | Direct | Sell | 12162025 | 5.00 | 2,000 | 10,000 | 1,975,910 | Form |
| 3 | Stewart, Michael G | Direct | Sell | 11212025 | 5.02 | 59,000 | 296,180 | 788,642 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Hanna, James Kevin | Senior VP, Controller & CAO | Direct | Buy | 8202026 | 4.15 | 2,300 | 9,545 | 2,251,392 | Form |
| 2 | Hooper, Rosa Handley | SVP of Operations | Direct | Sell | 12162025 | 5.00 | 2,000 | 10,000 | 1,975,910 | Form |
| 3 | Stewart, Michael G | Direct | Sell | 11212025 | 5.02 | 59,000 | 296,180 | 788,642 | Form |
Investor Activity (13F)
Updated Sep 1, 2026Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.
| Active Manager |
|---|
Industry Resources
| Real Estate Resources |
| The Real Deal |
| Commercial Observer |
| Inman |
| Health Care REITs Resources |
| Healthcare Real Estate Insights |
| Seniors Housing Business |
| RevistaMed |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.